Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics
Sign Up to like & getrecommendations! Published in 2023 at "Advanced Science"
DOI: 10.1002/advs.202205389
Abstract: Proteins are among the most common therapeutics for the treatment of diabetes, autoimmune diseases, cancer, and metabolic diseases, among others. Despite their common use, current protein therapies, most of which are injectables, have several limitations.… read more here.
Keywords: deep eutectic; subcutaneous injections; eutectic solvents; absorption ... See more keywords
Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2020.1720580
Abstract: Abstract Background Moderate-to-severe plaque psoriasis can be treated very successfully with systemic therapies. Often the therapeutics must be injected subcutaneously. This prospective observational study aimed to compare the correct preparation and performance of subcutaneous injections… read more here.
Keywords: subcutaneous injections; performance subcutaneous; injection; trained untrained ... See more keywords
SUBCUTANEOUS INJECTIONS: A CROSS-SECTIONAL STUDY OF KNOWLEDGE AND PRACTICE PREFERENCES OF NURSES.
Sign Up to like & getrecommendations! Published in 2023 at "Contemporary nurse"
DOI: 10.1080/10376178.2023.2209207
Abstract: BACKGROUND Widespread use of subcutaneous injection for parenteral medications is likely to be related to high medication bioavailability and rapid onset of action. Correct subcutaneous injection technique and site selection are essential for nursing care… read more here.
Keywords: injection; subcutaneous injection; practice; site ... See more keywords
Cytosine arabinoside constant rate infusion without subsequent subcutaneous injections for the treatment of dogs with meningoencephalomyelitis of unknown origin
Sign Up to like & getrecommendations! Published in 2020 at "Veterinary Record"
DOI: 10.1136/vr.106019
Abstract: Background The administration of cytosine arabinoside (CA) by continuous rate infusion (CRI) at the time of diagnosis has been shown to improve the 3-month survival of dogs diagnosed with meningoencephalomyelitis of unknown origin (MUO), compared… read more here.
Keywords: meningoencephalomyelitis unknown; subcutaneous injections; unknown origin; rate infusion ... See more keywords